search
Company Information
USD
3.31
- (-4.9%)
NASDAQ:RVNC, REVANCE THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 15 May 2024 GMT-4
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

Address

1222 Demonbreun Street
Suite 2000

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. Dustin S Sjuts
President
Mr. Angus Charles Russell
Director/Chairman of the Board
Ms. Jill Beraud
Director
Mr. Mark J. Foley
CEO/Director
Mr. Julian S. Gangolli
Director
Ms. Olivia C. Ware, M.B.A.
Director
Mr. Tobin C. Schilke
CFO/Chief Accounting Officer
Dr. Vlad Coric, M.D.
Director
Mr. Christian W. Nolet, C.P.A.
Director
Ms. Carey O’Connor Kolaja
Director
Mr. Dwight Moxie
General Counsel/Secretary/Senior VP

Ownership

Institution Holdings

Capital World Investors
11,939,076 (13.573%)
Capital Research and Management Company
11,928,994 (13.561%)
BlackRock Inc
7,453,371 (8.473%)
Franklin Advisers, Inc.
6,061,797 (6.891%)
Antara Capital LP
5,239,600 (5.957%)
Palo Alto Investors, LLC
5,237,284 (5.954%)
Palo Alto Investors LP
5,237,284 (5.954%)
Vanguard Group Inc
5,069,625 (5.763%)
Capital Group
5,032,000 (5.721%)
Franklin Resources Inc
4,749,539 (5.399%)

Individual Holdings

Mr. Mark J. Foley
985,468 (1.120%)
Mr. Tobin C. Schilke
205,849 (0.234%)
Mr. Dustin S Sjuts
179,728 (0.204%)
Mr. Dwight Moxie
149,209 (0.170%)
Ms. Erica Jordan
117,256 (0.133%)
Mr. Angus Charles Russell
36,506 (0.043%)
Mr. Julian S. Gangolli
30,106 (0.036%)
Ms. Jill Beraud
28,606 (0.034%)
Mr. Christian W. Nolet, C.P.A.
28,606 (0.034%)
Ms. Olivia C. Ware, M.B.A.
16,675 (0.020%)

Funds Holdings

American Funds New Economy Fund
5,032,000 (5.721%)
Capital Group New Economy Comp
5,032,000 (5.721%)
iShares Russell 2000 ETF
2,132,430 (2.424%)
JPMorgan Small Cap Growth Fund
1,577,791 (1.794%)
Franklin US Small Cap Growth Equity
1,536,492 (1.747%)
Vanguard Institutional Extnd Mkt Idx Tr
1,343,803 (1.528%)
Fidelity Small Cap Index Fund
871,616 (0.991%)
iShares Russell 2000 Growth ETF
780,121 (0.887%)
Invesco Small Cap Core
748,386 (0.851%)
iShares Biotechnology ETF
610,138 (0.694%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices